KA/EN
Register
Medicines reference
Search
Search
Product

Caniverm

Favourites

Fenbendazole + Pyrantel + Praziquantel · Bioveta

1 form: paste. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
Paste · Cat 0.49–2 kg Cat 0.49–2 kg 0.5 ml
0.5 ml of paste for 0.5-2 kg. Young animals every 3 weeks from 3 to 12 weeks, then every 3 months. Not with milky food.
 · Single dose		 Single dose Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: კანივერმი პერორალური პასტა
Verified on: 18 Oct 2026
Paste · Cat 2–5 kg Cat 2–5 kg 1 ml
1 ml of paste for 2.1-5 kg.
 · Single dose		 Single dose Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: კანივერმი პერორალური პასტა
Verified on: 18 Oct 2026
Paste · Dog 0.49–2 kg Dog 0.49–2 kg 0.5 ml
0.5 ml of paste for 0.5-2 kg. Young animals every 3 weeks from 3 to 12 weeks, then every 3 months. Not with milky food.
 · Single dose		 Single dose Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: კანივერმი პერორალური პასტა
Verified on: 18 Oct 2026
Paste · Dog 2–5 kg Dog 2–5 kg 1 ml
1 ml of paste for 2.1-5 kg.
 · Single dose		 Single dose Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: კანივერმი პერორალური პასტა
Verified on: 18 Oct 2026
Paste · Dog over 5 kg Dog over 5 kg 1 ml per 5 kg
Dogs above 5 kg: 1 ml per each 5 kg (0.2 ml/kg).
 · Single dose		 Single dose Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: კანივერმი პერორალური პასტა
Verified on: 18 Oct 2026
Details: pack, label wording, sources, registration

Caniverm, Paste

oral paste, fenbendazole 75 mg + pyrantel embonate 72 mg + praziquantel 25 mg per ml, oral paste for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full labelled treatment scope for susceptible intestinal roundworms and tapeworms in dogs and cats
7.9/10
Good
vetman assessment

Caniverm

oral paste, fenbendazole 75 mg + pyrantel embonate 72 mg + praziquantel 25 mg per ml, oral paste for dogs and cats
Assessed clinical scopeDog · Full labelled treatment scope for susceptible intestinal roundworms and tapeworms in dogs and cats · By mouth
Care settingWeight-based single-dose oral deworming after parasite-risk and label-band assessment
vetman score 7.9/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · Verified on 18 Oct 2026

A practical, officially documented broad-spectrum oral paste with sound ingredient-level support; confidence is moderated by limited independent exact-product trials.

Regulatory and scientific credibility8.5/10

The exact formulation is registered in Georgia and supported by a current Czech competent-authority or EU product dossier.

Clinical efficacy7.5/10

Fenbendazole, pyrantel and praziquantel provide rational broad intestinal nematode and cestode coverage; component and related-combination evidence is established, but robust independent trials of this exact three-drug product are limited.

Safety and tolerability7.5/10

The labelled safety profile is generally favourable, but piperazine or unplanned anthelmintic overlap, hepatic disease, pregnancy restrictions and dose-band limits require attention.

Clinical practicality8.0/10

The graduated paste supports small-patient dosing and direct oral delivery, but accurate weighing, applicator measurement and complete swallowing remain essential.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Complementary feed, not a veterinary medicine. Category-correct “not applicable” medicine-authorisation status does not establish regulator-reviewed efficacy, quantitative enzyme activity or safety.
  • The current manufacturer page names amylase and lipase but publishes no source, amount, activity units, protease, capsule-content mass, complete excipients, batch-potency limits or exact-product study. Do not infer a pancreatic-extract-equivalent dose.
Assessment sources
  1. UPD SPC 20262026
  2. Fenbendazole-praziquantel dog trial2017
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full labelled treatment scope for susceptible intestinal roundworms and tapeworms in dogs and cats
7.9/10
Good
vetman assessment

Caniverm

oral paste, fenbendazole 75 mg + pyrantel embonate 72 mg + praziquantel 25 mg per ml, oral paste for dogs and cats
Assessed clinical scopeCat · Full labelled treatment scope for susceptible intestinal roundworms and tapeworms in dogs and cats · By mouth
Care settingWeight-based single-dose oral deworming after parasite-risk and label-band assessment
vetman score 7.9/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · Verified on 18 Oct 2026

A practical, officially documented broad-spectrum oral paste with sound ingredient-level support; confidence is moderated by limited independent exact-product trials.

Regulatory and scientific credibility8.5/10

The exact formulation is registered in Georgia and supported by a current Czech competent-authority or EU product dossier.

Clinical efficacy7.5/10

Fenbendazole, pyrantel and praziquantel provide rational broad intestinal nematode and cestode coverage; component and related-combination evidence is established, but robust independent trials of this exact three-drug product are limited.

Safety and tolerability7.5/10

The labelled safety profile is generally favourable, but piperazine or unplanned anthelmintic overlap, hepatic disease, pregnancy restrictions and dose-band limits require attention.

Clinical practicality8.0/10

The graduated paste supports small-patient dosing and direct oral delivery, but accurate weighing, applicator measurement and complete swallowing remain essential.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Complementary feed, not a veterinary medicine. Category-correct “not applicable” medicine-authorisation status does not establish regulator-reviewed efficacy, quantitative enzyme activity or safety.
  • The current manufacturer page names amylase and lipase but publishes no source, amount, activity units, protease, capsule-content mass, complete excipients, batch-potency limits or exact-product study. Do not infer a pancreatic-extract-equivalent dose.
Assessment sources
  1. UPD SPC 20262026
  2. Fenbendazole-praziquantel dog trial2017
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fenbendazole75 mg/ml Pyrantel72 mg/ml Praziquantel25 mg/ml
Formulation Type
Paste
Administration route
By mouth
Manufacturer
Bioveta · Czechia
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: კანივერმი პერორალური პასტა
Verified on: 18 Oct 2026
 EU Yes, veterinary
№ 96/026/12-C
Verified on: 18 Oct 2026
 UK No
Verified on: 18 Oct 2026
 US No
Verified on: 18 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
0.5 ml
0.5 ml of paste for 0.5-2 kg. Young animals every 3 weeks from 3 to 12 weeks, then every 3 months. Not with milky food.
 Cat 0.49–2 kg By mouth Single dose
UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
CANIVERM oral paste - SPC (Czech Republic)
EU Union Product Database, 2026
1 ml
1 ml of paste for 2.1-5 kg.
 Cat 2–5 kg By mouth Single dose
UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
CANIVERM oral paste - SPC (Czech Republic)
EU Union Product Database, 2026
0.5 ml
0.5 ml of paste for 0.5-2 kg. Young animals every 3 weeks from 3 to 12 weeks, then every 3 months. Not with milky food.
 Dog 0.49–2 kg By mouth Single dose
UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
CANIVERM oral paste - SPC (Czech Republic)
EU Union Product Database, 2026
1 ml
1 ml of paste for 2.1-5 kg.
 Dog 2–5 kg By mouth Single dose
UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
CANIVERM oral paste - SPC (Czech Republic)
EU Union Product Database, 2026
1 ml per 5 kg
Dogs above 5 kg: 1 ml per each 5 kg (0.2 ml/kg).
 Dog over 5 kg By mouth Single dose
UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
CANIVERM oral paste - SPC (Czech Republic)
EU Union Product Database, 2026
Active substance doses, with sources
Active substance Fenbendazole
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
100 mg/kg Dog, Cat Maintenance By mouth once
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Panacur small animal 100 mg/ml oral suspension - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2025
Active substance Pyrantel
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
14.4 mg/kg Dog Maintenance By mouth once
VMD SPC 2022
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Krka Multiwormer 50/144/150 mg tablets for dogs - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2022
20 mg/kg Cat Maintenance By mouth once
VMD SPC 2024
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Krka Wormer 230 mg/20 mg film-coated tablets for cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2024
Active substance Praziquantel
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
5 mg/kg Dog, Cat Maintenance By mouth once
VMD SPC 2022
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Krka Multiwormer 50/144/150 mg tablets for dogs - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2022
VMD SPC 2024
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Krka Wormer 230 mg/20 mg film-coated tablets for cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2024

Known Contraindications

  • Critical Praziquantel
    Do not use in cases of known hypersensitivity to the active substances or to any of the excipients.
    Sources: VMD SPC · VMD
  • Critical Pyrantel (Dog)
    Do not use in dogs younger than 2 weeks of age and/or weighing less than 2 kg.
    Sources: VMD SPC · VMD · FDA
  • Critical Pyrantel (Cat)
    Do not use in kittens less than 6 weeks of age.
    Sources: VMD SPC · VMD
  • Warning Pyrantel (Cat)
    The safety of the veterinary medicinal product has not been established during pregnancy. The product should not be used during pregnancy but may be used during lactation.
    Sources: VMD SPC · VMD

Known Drug Interactions

  • Minor warning Fenbendazole + Methimazole
    Thiamazole reduces hepatic oxidation of benzimidazole anthelmintics and can increase their plasma concentrations during concurrent treatment.
    Recommendation: Higher fenbendazole concentrations are expected during concomitant administration.

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (80 more) Hide additional products

Same therapeutic group 80

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 18 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗